We report a rare case of subcutaneous phaeohyphomycosis caused by Cladophialophora bantiana in an immunocompetent patient in Amazonas, Brazil. This dematiaceous fungus has been mainly associated with life-threatening infections affecting the central nervous systems of immunosuppressed patients. We present the clinical, laboratory, and therapeutic aspects, and in vitro susceptibility test results for different antifungal drugs. A brief review of the cases reported in the literature over the past 20 years has also been discussed. According to the literature review, the present case is the first report of subcutaneous phaeohyphomycosis due to C. bantiana in an immunocompetent patient in Latin America.
INTRODUCTION
Phaeohyphomycosis is a group of mycotic diseases caused by dematiaceous fungi; these diseases range from superficial to deep infections and affect both immunocompetent and immunocompromised patients. In clinical practice, this term is most commonly used for some sporadic mycoses with wide clinical and etiological diversity, thus excluding classic clinical entities such as chromomycosis, black-grain mycetoma, and tinea nigra. Underlying disease, treatment with immunosuppressive drugs, solid organ transplantation, and traumatic inoculation are among the main reported predisposing factors. Several fungal species have been isolated, including Exophiala jeanselmei, E. spinifera, E. dermatitidis, Cladosporium sp., Cladophialophora sp., Curvularia sp., and Alternaria sp. [1] [2] [3] In a recent review of the literature, we found few reports of subcutaneous phaeohyphomycosis caused by C. bantiana. The majority of cases associated with this fungal species were cerebral fungal infections usually causing single or multiple brain abscesses with rapid evolution and high mortality rates. C. bantiana has been highlighted as the main causative agent of phaeohyphomycosis of the central nervous system and is, therefore, considered a true neurotropic fungus. Extracerebral infectious conditions caused by this fungus, such as pulmonary infections, sinusitis, septic arthritis, and subcutaneous phaeohyphomycosis, are uncommon 3, 4 .
Subcutaneous phaeohyphomycosis has a diverse etiology with different clinical types and manifests as polymorphic lesions, including subcutaneous cysts, erythematous-squamous lesions, pustules, granulomatous crusts, cutaneous abscesses, and serosanguineous exudate, and other manifestations. The infection mostly occurs following traumatic inoculation of a saprobic fungus into the subcutaneous tissue. The phaeohyphomycotic cyst is the most recurrent reported form and the most common presentation is a solitary, asymptomatic, well-encapsulated subcutaneous mass. Exophiala jeanselmei and E. dermatitidis are among the most common isolated agents from this clinical form 1, 3, [5] [6] [7] .
CASE REPORT
A 60-year-old male rural worker from Humaitá (Amazonas state, Brazil) presented with a cutaneous asymptomatic lesion in the distal third of his left forearm that had persisted for two months before the office visit. The patient was a diabetic and well-controlled hypertensive, with normal blood glucose and blood pressure levels due to the use of antidiabetic and antihypertensive drugs. The clinical examination revealed an encrusted, friable, erythematous, violaceous plaque with multiple orifices and purulent drainage ( Figure 1A) . Laboratory findings such as blood count, renal and hepatic function, and glycosylated hemoglobin levels were normal. HIV serology was negative. Nocardiosis and cutaneous tuberculosis were the initial diagnostic hypotheses. For laboratory confirmation, biopsy fragments from two different sites were collected using a punch biopsy instrument (4 mm). The samples obtained were submitted for histopathological and culture examination for bacteria and fungi.
Direct mycological examination with KOH (20%) revealed some dematiaceous, septate, and tortuous hyphae and isolated or paired dematiaceous yeast-like cells (Figure 2A) . Histopathological examination showed the epidermis with hyperkeratosis, parakeratosis, fibrin-leukocyte crust, and irregular acanthosis. A pronounced inflammatory infiltrate consisting of lymphocytes, histiocytes, plasmocytes, polymorphonuclear neutrophils, and multinucleated giant cells was observed in the dermis. Septate and brownish hyphae were seen and small rounded, brownish structures were present in the interstice and inside of multinucleated giant cells.
( Figure 2B) . The fungal colony grew on Mycosel agar (DIFCO ® ) and Sabouraud dextrose agar (DIFCO ® ) with chloramphenicol (0,05 g/L). Based on its phenotypic features, the fungus was identified as C. bantiana. Macromorphological analysis on potato dextrose agar (PDA) revealed a colony with moderately fast growth, olive green color, velvet-like texture, and discreetly grooved topography ( Figure 2C ). Micromorphological analysis using the Riddell technique demonstrated dematiaceous septate hyphae, blastic-acropetal conidiogenesis with long chains of ellipsoidal conidia commonly developing directly from the primary hyphae or from short and poorly differentiated conidiophores, and frequent chains of conidia without branches or with only sparse ramifications ( Figure 2D) . was performed with an initial denaturation at 96°C for 5 min, followed by 35 cycles of 95°C for 1 min, 55°C for 1 min, and 72°C for 1 min, and a final extension at 72°C for 10 min. The PCR products were sequenced on an ABI 3130 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA) using a BigDye Terminator Cycle Sequencing Kit v3.1 (Applied Biosystems, USA) according to the manufacturer's guidelines. The DNA sequence chromatogram files were analyzed using Phred and BioEdit software (quality ≥ 20) and the nucleotide sequence was added to the National Center for Biotechnology Information (NCBI) GenBank (accession number MH445303). The nucleotide sequence was compared to those deposited in the database using the BLASTn tool (https://blast.ncbi.nlm. nih.gov/Blast.cgi); the sequence had a 99% identity with more than 20 C. bantiana isolates (strains LT837815.1, KY432483.1, KP131825.1, and AF131079.1, among others). In addition, we performed phylogenetic analysis based on the ITS sequences and constructed a phylogenetic tree using MEGAX software with 100 bootstrap replicates to show the relationship between our strain and other strains of C. bantiana (data not shown).
In vitro antifungal susceptibility tests were performed according to the Clinical and Laboratory Standards Institute (CLSI) M38-A2 guidelines. The minimum inhibitory concentrations (MICs) of posaconazole, itraconazole, amphotericin B, terbinafine, and fluconazole were 0.25, 2, 4, 8, and >16 ug/mL, respectively. Initially, the patient was administered fluconazole without clinical response after 30 days of treatment. Currently, the patient is under treatment with itraconazole 200 mg twice daily with lesion regression but without complete healing after 10 months (Figure 1B) . The patient remains on antifungal treatment and cryotherapy was recently performed.
DISCUSSION
To our knowledge, this report describes the first case of C. bantiana diagnosed in an immunocompetent patient in Latin America. The patient was a well-controlled diabetic with normal laboratory findings and no evidence of an immunocompromised status.
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There are few reports of subcutaneous phaeohyphomycosis caused by C. bantiana and many questions about its ecoepidemiology and pathogenesis lack elucidation. Despite this, we can observe some common features in most cases reported so far. We found 12 reports published between 1987 and 2018; however, three described the same patient in Texas, USA [8] [9] [10] . Therefore, 10 cases reported involvement in adults of all age groups, including seven women and four men; one of the case reports involved a Swedish man and woman that sustained injuries during a tsunami catastrophe in Thailand 15 . Most of the cases were immunosuppressed due to underlying diseases and prolonged use of corticosteroids. Only two cases occurred in immunocompetent patients; both were female and were affected on the face. In the first case, the patient possibly contracted the infection through the continuous use of cosmetics in a beauty parlor (attributed to her sales profession) that caused microscopic lesions on her face, favoring the inoculation of the fungus 5 . In the second case, the transmission was via the conventional route, in which the patient suffered traumatic inoculation on the face due to an accident involving a twig 7 . Table 1 summarizes these cases.
The natural habitat of C. bantiana is unknown, although most reports refer to traumatic inoculation of the fungus due to accidents with material contaminated with soil or plants, as in the present case. According to the cases listed in Table 1 , the limbs and trunk are the most affected anatomical sites.
Three similar cases were reported with probable implantation of fungi after traumatic accidents. In the first case, the active infection occurred 16 years after the injury due to the establishment of systemic immunosuppression caused by systemic lupus erythematosus and prednisone therapy [8] [9] [10] . The other cases occurred after corticosteroid injections that caused local immunosuppression [11] [12] [13] . The authors suggest possible fungal latency for years and the reactivation of infection after the development of an immunosuppressive state.
We observed different clinical aspects, such as erythematous plaques and nodular and ulcerogenic lesions, from those reported in most cases by other agents of subcutaneous phaeohyphomycosis, which are usually a solitary cystic lesion or an encapsulated tumor mass. Khader, et al. (2015) reported a case of an immunosuppressed patient who presented three types of lesions with distinct morphological patterns: pyogenic granuloma-like nodules in the lower limbs, dermatophytosislike plaques in the foot, and subcutaneous cyst in the hand 14 .
Concomitant late tissue infections by C. bantiana and Mycobacterium abscessus were reported by Petrini, et al. (2006) , following tsunami-associated injuries and subsequent partial-thickness skin grafts after multiple surgical revisions 15 .
This report describes a case of subcutaneous phaeohyphomycosis caused by the unusual C. bantiana fungus. The evidence pointed to traumatic implantation of the fungus into the patient's skin due to his occupation as a rural worker. Unlike most reported cases, no significant immunosuppressive factor was evidenced in this case. However, he remains without cure after 10 months of treatment with itraconazole. While the optimal therapy has not yet been established, itraconazole is the drug of choice in the dose range of 200-600 mg per day.
